Medical and Scientific Translation Across Canada Contact us Français

Home/Industries/Biotech Translation Services

Biotech Translation Services

From early research and patent filings to CMC technology transfer, first clinical trials and investor communications, biotech startups work across borders at every stage. Mediwords translates specialized scientific, technical and business documents for biotechnology companies and their partners, with confidential handling and terminology that follows the program as it grows.

Get a quote
  • NDA first
  • CMC documents
  • Investor decks
Biotech scientist reviewing a translated manufacturing document next to bioreactor equipment

Trusted by healthcare and life sciences organizations

  • Dexcom logo, client of Mediwords
  • Canadian Cancer Society logo, client of Mediwords
  • Allianz logo, client of Mediwords
  • Sun Life logo, client of Mediwords
  • YMCA New Brunswick logo, client of Mediwords
  • Sinai Health logo, client of Mediwords

Biotech Translation for Startups and Scale-Ups

Early-stage biotech teams need accurate language versions of research summaries, patent documents, manufacturing records, clinical trial materials and investor presentations. Mediwords helps founders, scientific directors, regulatory consultants and CROs work with overseas partners while keeping specialized terminology consistent across documents.

Small teams often manage several workstreams with limited internal resources. A chief scientific officer may need a technology transfer package in English, a founder may need a presentation for international investors, and a clinical team may need Canadian French participant materials. We agree on the scope, intended audience and delivery priorities before translation begins.

Mediwords works only on medical, pharmaceutical and scientific content. Our translators work into their mother tongue and are selected for the subject: molecular biology, immunology, bioprocessing, clinical research.

Translation Needs at Each Stage of a Biotech Company

The documents change as the company grows:

StageWhat biotech teams send usWhy it is needed
Research and seedGrant applications, scientific summaries, publicationsFunders, collaborators and journals in another language
Intellectual propertyPatent applications, claims, office correspondenceNational phase filings in other countries and languages
Process development and CMCTechnology transfer packages, batch records, certificates of analysis, method validation reportsContract manufacturers abroad and your own quality team
First clinical trialProtocol, investigator brochure, consent formsEthics boards, investigators and participants
Financing and partneringInvestor decks, non-confidential summaries, data room documentsInvestors and partners in other markets
LicensingScientific annexes and due diligence documentsA partner preparing to take over the program

Confidentiality Comes Before the First Word

Biotech documents may contain unpublished results, proprietary processes, confidential commercial information or inventions that have not yet been filed. We can sign your non-disclosure agreement before receiving sensitive files, limit access to the assigned project team and follow agreed handling instructions. Your team decides which information can be disclosed and to whom.

For patent filings, language and procedural deadlines depend on the jurisdiction and filing route. Under the US PCT national-stage framework, the usual 30-month period concerns national-stage entry requirements, while a missing English translation may be subject to a separate notice and later deadline. See the USPTO guidance on national-stage entry and translations. Our pharmaceutical patent translation service works with your patent agent on the required text and format; your patent professional remains responsible for filing strategy, deadlines and submission. Our security and confidentiality page explains our approach to file handling.

Where Biotech Documents Are Hard to Translate

New modalities

Antibody-drug conjugates, mRNA products and cell or gene therapies combine emerging terminology with established scientific nomenclature. We follow approved reference documents and flag inconsistent names rather than silently changing gene, protein or construct identifiers.

CMC and process language

Technology transfer packages, process descriptions, critical quality attributes, potency assays and specifications require consistent terminology across sites. We translate the approved source faithfully; process approval and GMP compliance remain with your quality and manufacturing teams.

Numbers inside the science

Concentrations, titres, EC50 values, units and significant figures are checked against the source as part of linguistic quality assurance. Our team does not independently validate experimental results or recalculate process data.

Partners Abroad, Documents in Other Languages

We translate biotechnology documents into and from English, Canadian French and more than 30 other languages. Common project scenarios include:

  • German to English: documents from contract manufacturers, suppliers and academic partners in Germany, Austria and Switzerland. Our German medical translation page explains this pair.
  • French to English: Quebec biotechs preparing a US filing, a publication or an investor round
  • English to Canadian French: consent forms and participant materials for trial sites in Quebec and other francophone communities
  • Chinese, Japanese and Korean to English: certificates, supplier documents and partner study reports

For multinational projects, we coordinate specialist translators using shared approved terminology, while preserving the document conventions required by each target market.

Grant Applications and Non-Dilutive Funding

Grant and research funding applications often contain scientific summaries, research plans, milestones and budget justifications. Language and submission rules differ by program, competition and funder, including programs administered by the Canadian Institutes of Health Research and the Fonds de recherche du Québec. Your team should confirm the current language and document requirements for each funding opportunity before translation starts.

We translate approved scientific and supporting materials between English and Canadian French, preserving the research objectives, technical detail and financial terminology. We do not determine eligibility, prepare funding strategy or submit applications on the applicant’s behalf.

Your First Clinical Trial in Canada

Early-phase clinical trials may involve regulatory and ethics documents such as protocols, investigator brochures, informed consent forms and participant-facing materials. The precise documentation, language requirements and review pathways depend on the product, study and applicable Health Canada and research ethics board requirements. We translate the materials selected by your regulatory and clinical teams; they remain responsible for determining what must be submitted or approved.

Small sponsors often discover the translation workload late, when the protocol is final and the first site is waiting. Planning translation of the consent form and questionnaires as soon as the English is stable, and updating them amendment by amendment, avoids that bottleneck.

Biotech Translation or Pharmaceutical Translation?

Biotechnology and pharmaceutical translation overlap throughout product development. This industry page focuses on the needs of biotech startups and scale-ups, from research and patents to manufacturing partnerships, financing and early trials. Our pharmaceutical translation service covers specialized drug-development, regulatory, safety and commercial content across different types of pharmaceutical organizations.

We can use shared approved terminology across the investigator brochure, clinical documents, CMC records and subsequent materials, while updating the glossary whenever your scientific and regulatory teams approve a change. Consistent terminology supports review; it does not replace regulatory or scientific approval.

Working With Your Consultants and Partners

Startup teams frequently collaborate with patent agents, regulatory consultants, CROs, contract manufacturers and investors. With your authorization, we can coordinate delivery and reference materials with the relevant contacts while keeping one central terminology record and agreed access controls.

This reduces avoidable differences between documents translated for separate workstreams. We preserve approved product names, scientific concepts and document references, flag potential inconsistencies, and leave final technical or legal approval to your specialists.

How We Work With a Small Biotech Team

  1. One contact. One project manager follows your files, whatever the department that sends them.
  2. Clear scope and schedule. We confirm a written quote and a feasible delivery date after reviewing the files and requirements.
  3. Your terms first. We build a short glossary from your publications, patents and approved documents.
  4. Room to grow. When volumes increase, more translators join the same glossary and memory instead of starting over.

Biotech Translation FAQ

Can you translate a document before our patent application is filed?

Yes. We can sign an NDA before receiving unpublished material and restrict access to the assigned team. Translation does not replace advice from your patent agent about disclosure, novelty, filing strategy or deadlines.

Do you translate documents from contract manufacturers abroad?

Yes. We translate technology transfer packages, batch records, certificates of analysis, process descriptions and validation documents in the agreed language combinations. Your manufacturing and quality teams review and approve the technical content.

Can you translate an investor presentation?

Yes. We translate investor decks, scientific summaries and approved data-room materials, preserving specialist terminology and PowerPoint formatting. Your company approves financial and scientific claims before external distribution.

Do you handle the documents for our first clinical trial?

Yes. We translate protocols, investigator brochures, informed consent forms and participant questionnaires. Your sponsor and regulatory teams determine the submission scope, required languages and applicable approvals.

How do you keep gene and protein names correct?

We preserve standardized names, gene symbols, protein identifiers and construct codes where appropriate, following approved source documents and nomenclature references. Unclear or inconsistent terminology is flagged for your scientific team.

Is this different from pharmaceutical translation?

Biotech translation covers research, patents, manufacturing partners, financing and early trials. Labels, monographs and post-approval documents are covered by our pharmaceutical translation service.

Can you translate a contract manufacturer's documents into French for our Quebec site?

Yes. Procedures, batch records and certificates can be translated into Canadian French for staff at a Quebec facility, with the same glossary as the English versions.

Can you work directly with our patent agent?

Yes, with your authorization. We can coordinate files, terminology and formatting with your patent agent, who remains responsible for legal requirements, deadlines and filing.

Can you translate grant applications for Canadian and Quebec funders?

Yes. We translate research plans, summaries and supporting documents into English or French, depending on the funder, and you remain the one who submits.

Do you offer interpretation for partner meetings?

No. Mediwords provides written translation only.

Can you support ongoing CMC and clinical document updates?

Yes. We can maintain approved terminology and translation memories across versions, identify changed passages and coordinate updates for multiple languages. Your document owner confirms the version to be translated and approves the final controlled document.

Get a Quote for Your Biotech Documents

Send us your documents, the languages you need and your deadline. We can sign your NDA first. We reply within one business day with a fixed price and a delivery date. You can also write to us at info@mediwords.ca.